LP-661438

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLP-661438
Drug Alias NameLP-661438
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDeoxycytidine kinase inhibitors
TargetsDeoxycytidine kinase
Therapy Area/IndicationsLymphomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLexicon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLexicon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLymphomaLeukemia

Other Information

ATC CodeN/A
Related LinksN/A